{"filings":[{"id":787196,"accession_number":"0001568651-26-000048","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2026-06-02T10:31:58+00:00","items":["5.02"],"status":"ready","headline":"Oscar Health Co-Founder Schlosser transitions from CTO to Advisor to CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["New role as Co-Founder & Advisor to CEO effective June 1, 2026; continues to serve on Board.","Annual base salary set at $370,000; no longer eligible for annual bonus starting 2026.","Will not receive future equity awards; existing equity continues to vest per original terms.","No cash severance or subsidized healthcare upon termination of employment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93738,"accession_number":"0001568651-26-000036","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2026-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health Q1 net income $679M ($2.07 EPS) vs $275M ($0.92) YoY; revenue $4.65B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $4.65B, up 53% YoY from $3.05B; net income $679M ($2.07 EPS) vs $275M ($0.92 EPS) YoY.","Medical loss ratio improved to 70.5% from 75.4% YoY; SG&A ratio 15.2% from 15.8%.","Membership increased to ~3.17M from ~2.04M, up 55% YoY.","Adjusted EBITDA $727M vs $329M YoY; Company reaffirms full-year 2026 guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":2.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":4647194000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93737,"accession_number":"0001568651-26-000028","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2026-04-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Oscar Health appoints new Board Chair, Siddhartha Sankaran, effective June 4","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Siddhartha Sankaran appointed independent Chair of Board, effective June 4, 2026.","Succeeds Jeffery Boyd, who served as Chair since Feb 2021 and is not standing for reelection.","Sankaran has over 20 years insurance experience, including executive roles at AIG, SiriusPoint, FWD Group.","CEO Mark Bertolini expressed confidence in Sankaran leading Board through next phase of growth.","Boyd's tenure included Oscar's IPO and transformation from startup to individual market leader."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105603,"accession_number":"0001568651-26-000014","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2026-03-02T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health reaffirms FY 2026 guidance at Raymond James conference","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Participating in the 2026 Raymond James Institutional Investors Conference on March 2, 2026.","Reaffirming full-year 2026 guidance previously announced on Feb 10, 2026 in Q4/FY2025 earnings release.","No new financial metrics or changes to prior guidance disclosed in this filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":105602,"accession_number":"0001568651-26-000008","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2026-02-10T23:59:59+00:00","items":["1.01","2.02","2.03","9.01"],"status":"ready","headline":"Oscar Health reports record 3.4M members, FY2025 net loss $443M; guides FY2026 revenue $18.7-$19B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full-year 2025 net loss $443.2M ($1.69 diluted EPS) vs prior-year net income $25.4M ($0.10 diluted EPS).","Record membership of ~3.4 million as of Dec 31, 2025, up from 1.68 million a year earlier.","FY2025 total revenue $11.7B (up 27% YoY); medical loss ratio 87.4% (vs 81.7% in 2024).","FY2026 guidance: revenue $18.7-$19.0B, MLR 82.4-83.4%, SG&A ratio 15.8-16.3%, operating earnings $250-$450M.","Entered into $475M secured three-year revolving credit facility (Feb 6, 2026) for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.69,"consensus_revenue_estimate":null,"consensus_revenue_actual":11701427000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121887,"accession_number":"0001193125-25-335294","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-12-29T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Oscar Health amends CEO Bertolini's employment agreement; $45M equity grant, base salary $1.3M","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["New term from Dec 22, 2025 to Apr 1, 2029, with automatic one-year renewals unless either party elects not to extend.","Annual base salary set at $1.3M; target bonus increased to 150% of base starting in 2026.","$45M in RSU awards granted Q1 2026: 50% time-vesting over three years, 50% performance-based.","Enhanced severance: 1.5x cash multiplier and 18 months of healthcare upon without-cause or good reason termination.","Mr. Bertolini not eligible for other long-term equity awards until calendar year 2029."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121886,"accession_number":"0001568651-25-000035","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Oscar Health Q3 net loss $137.5M ($0.53 EPS); exchanges $187.5M notes for 23.3M shares","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 total revenue $2.99B (+23% YoY); net loss $137.5M vs $54.6M loss YoY; Adj EBITDA loss $101.5M vs $11.6M loss.","Medical loss ratio 88.5% (vs 84.6% YoY) driven by $130M increase in risk adjustment accrual; SG&A ratio improved to 17.5%.","Reaffirmed FY2025 guidance: revenue $12.0-12.2B, loss from operations $200-300M, MLR 86-87%.","On Nov 5, exchanged $187.5M of 7.25% convertible notes due 2031 for 23.3M shares; up to $62.5M more by Dec 14.","Debt covenants extinguished; $410M subordinated notes due 2030 no longer subordinated to 2031 notes."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":8896192000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138578,"accession_number":"0001193125-25-207417","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-09-18T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Oscar Health issues $410M of 2.25% convertible notes due 2030; net proceeds ~$395.8M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Notes carry 2.25% coupon, mature Sep 1, 2030; initial conversion price ~$24.82 per share.","Net proceeds of ~$395.8M used $34.4M for capped calls; balance for AI, care cost reduction, growth.","Initial purchasers fully exercised $55M option; capped calls cap price $37.46 per share.","Notes subordinated to senior debt; structurally subordinated to subsidiary liabilities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138577,"accession_number":"0001193125-25-204231","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-09-16T23:59:59+00:00","items":["1.02","8.01","9.01"],"status":"ready","headline":"Oscar Health prices $355M 2.25% convertible notes due 2030; uses proceeds for growth and AI","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Upsized offering of $355M (from $350M); 2.25% interest, due September 1, 2030.","Net proceeds ~$342.5M (or ~$395.8M if initial purchasers exercise $55M option).","Initial conversion price $24.82/share, a 32.5% premium to $18.73 closing price.","Capped call transactions with cap at $37.46/share (100% premium) to reduce dilution.","Will terminate revolving credit facility contingent on closing of the offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138576,"accession_number":"0001193125-25-203549","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-09-15T23:59:59+00:00","items":["1.01","7.01","8.01","9.01"],"status":"ready","headline":"Oscar Health proposes $350M convertible notes due 2030; to fund AI, growth initiatives","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$350M principal amount of convertible senior subordinated notes due 2030; underwriters option for additional $52.5M.","Net proceeds for general corporate purposes, including AI initiatives, lowering cost of care, and potential extension of enhanced premium tax credits.","Notes subordinated to senior debt; interest rate and conversion price set at pricing; redeemable after Sep 2028 if stock exceeds 130% conversion price.","Expects to enter capped call transactions to offset dilution upon conversion; counterparties may hedge affecting stock price.","Plans to terminate revolving credit facility with Wells Fargo upon closing of the offering; amendment with Dragoneer permits offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138575,"accession_number":"0001193125-25-194448","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-09-03T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health reaffirms FY2025 guidance at Wells Fargo conference","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Reaffirmed updated full-year 2025 guidance first provided July 22, 2025.","Participating in 2025 Wells Fargo Healthcare Conference on September 3, 2025.","No new financial information or changes to outlook disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138574,"accession_number":"0001568651-25-000021","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health Q2 net loss $228.4M, MLR 91.1% vs 79.0% YoY; revenue up 29%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue: $2.86B, up 29% YoY from $2.22B on higher membership, partly offset by risk adjustment accrual.","Medical loss ratio worsened to 91.1% from 79.0%, driven by higher market morbidity and net risk adjustment accrual.","Net loss attributable to Oscar of $228.4M ($0.89 per diluted share) vs net income of $56.2M ($0.20) in Q2 2024.","Adjusted EBITDA loss $199.4M, compared to positive $104.1M a year ago; SG&A ratio improved to 18.7% from 19.6%.","Reaffirmed full-year 2025 outlook; membership grew 28% to 2.03M; Cigna+Oscar members fell from 58k to 10k."],"consensus_eps_estimate":null,"consensus_eps_actual":0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":5910208000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138573,"accession_number":"0001568651-25-000018","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-07-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health expects Q2 operating loss ~$230M; cuts FY2025 guidance on higher ACA risk scores","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 expects loss from operations of ~$230M and net loss of ~$228M.","FY2025 guidance revised: Total Revenue $12.0B-$12.2B, MLR 86-87%, Operating loss ($300M)-($200M).","Cost trends moderated vs Q1 but utilization remains elevated; plans 2026 rate resubmissions covering ~98% of membership.","2024 risk adjustment results $23M favorable to prior accruals.","Adjusted EBITDA expected to be ~$120M better than operating loss."],"consensus_eps_estimate":null,"consensus_eps_actual":0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":5910208000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":156024,"accession_number":"0001193125-25-137039","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-06-06T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Oscar Health stockholders elect nine directors, ratify auditor, approve say-on-pay at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All nine director nominees elected; highest vote FOR Mark T. Bertolini (804M), lowest Mario Schlosser (799M).","Ratification of PricewaterhouseCoopers as auditor for FY2025: 825,271,165 FOR, 581,597 against.","Advisory vote on executive compensation approved: 801,338,734 FOR, 3,246,195 against.","Quorum achieved with 825,961,296 votes cast out of 929,277,354 available."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":156023,"accession_number":"0001568651-25-000012","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health reports Q1 2025 revenue of $3.05B, net income $275M, and reaffirms full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue rose 42% year-over-year to $3.046 billion for Q1 2025, driven by higher membership.","Net income attributable to Oscar Health grew to $275.3 million ($0.92 per diluted share) from $177.4 million.","Adjusted EBITDA increased to $328.8 million, up from $219.3 million in the prior-year quarter.","Membership reached 2,039,467 effectuated members, a 41% increase compared to Q1 2024.","Company reaffirms full-year 2025 outlook across all metrics as previously provided on February 4, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":0.92,"consensus_revenue_estimate":null,"consensus_revenue_actual":3046263000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":174490,"accession_number":"0001193125-25-043364","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-03-03T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health reaffirms FY2025 guidance at Raymond James conference","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company participates in 2025 Raymond James Institutional Investors Conference on March 3.","Reaffirms full year 2025 guidance originally provided on Feb 4, 2025 in Q4 2024 earnings release.","No new financial information or changes disclosed in this filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":174489,"accession_number":"0001568651-25-000005","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2025-02-04T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Oscar Health reports first-ever positive net income of $25.4M in 2024; appoints new insurance president","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total Revenue $9.2B (+56.5% YoY); Net income $25.4M ($0.10 diluted EPS) vs loss of $270.7M in 2023.","Adjusted EBITDA $199.2M, a $244.5M improvement YoY, marking first year of profitability on this metric.","2025 guidance: Revenue $11.2-11.3B, MLR 80.7-81.7%, SG&A 17.6-18.1%, Earnings from Operations $225-275M.","Janet Liang appointed EVP & President of Oscar Insurance, effective Feb 24, 2025; COO Steven Wolin resigned.","Membership grew to 1.68M (+62% YoY); Individual & Small Group members 1.64M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.1,"consensus_revenue_estimate":null,"consensus_revenue_actual":9177564000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":191446,"accession_number":"0001568651-24-000029","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health Q3 revenue $2.4B (+68% YoY); narrows loss; raises FY revenue guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $2.4B, +68% YoY; net loss $54.6M ($0.22 EPS) improved $10.8M YoY.","Membership grew to 1.65M from 983k YoY, driven by Individual and Small Group (1.60M).","Adjusted EBITDA loss $11.6M, improved $8.7M YoY; SG&A expense ratio improved to 19.0% from 22.6%.","FY2024 revenue guidance raised to $9.2-9.3B; expects net income profitability this year.","Medical Loss Ratio 84.6%, up 80bps YoY due to higher medical costs and risk adjustment."],"consensus_eps_estimate":null,"consensus_eps_actual":0.65,"consensus_revenue_estimate":null,"consensus_revenue_actual":6785128000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207924,"accession_number":"0001193125-24-212607","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2024-09-04T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health to reaffirm FY2024 guidance at three investor conferences in Sept 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company participates in Wells Fargo Conference Sept 4, Morgan Stanley Conference Sept 5, and Baird Conference Sept 11.","Management will reaffirm the updated full-year 2024 guidance from the Q2 2024 earnings release (Aug 7, 2024).","Presentations webcast; access details on ir.hioscar.com investor relations page."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207923,"accession_number":"0001568651-24-000021","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Oscar Health Q2 net income $56.2M, rev $2.2B +46% YoY, raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income of $56.2M ($0.20 diluted EPS) vs. loss of $15.5M a year ago.","Total revenue $2.2B, up 46% YoY driven by higher membership and rate increases.","Adjusted EBITDA $104.1M, up from $35.6M in Q2 2023; MLR improved 90bps to 79.0%.","Raised FY 2024 revenue guidance to $9.0-9.1B (prior $8.3-8.4B) and Adj EBITDA to $160-210M (prior $125-175M).","Total membership 1.58M, up 63% YoY, driven by Individual & Small Group growth."],"consensus_eps_estimate":null,"consensus_eps_actual":0.82,"consensus_revenue_estimate":null,"consensus_revenue_actual":4361646000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":225425,"accession_number":"0001193125-24-159132","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2024-06-11T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Oscar Health holds 2024 Annual Meeting; all director nominees and proposals approved","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Ten director nominees elected; top vote getter Mark T. Bertolini with 840.4M votes for.","Ratification of PwC as auditor for FY2024 approved with 861.7M votes for.","Advisory say-on-pay proposal approved with 790.9M votes for (91.7% of votes cast).","Quorum of 862.2M votes out of 911.8M total votes represented."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":225424,"accession_number":"0001193125-24-156438","cik":1568651,"company_name":"Oscar Health, Inc.","ticker":"OSCR","form_type":"8-K","filed_at":"2024-06-07T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Oscar Health reconfirms FY2024 guidance, to provide updated strategic targets at Investor Day","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Reaffirms full-year 2024 guidance as provided in Q4 2023 earnings release dated Feb 7, 2024.","Will update on Adjusted EBITDA performance through April 30, 2024.","To discuss long-term growth targets and strategic levers at June 7 Investor Day."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":6777826839.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}